GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial

PURPOSE: The purpose this study is to investigate whether a double antagonist dose (0.25 mg/12 h) administered the day before hCG trigger is effective in preventing ovarian hyperstimulation syndrome (OHSS) in GnRH antagonist IVF/intracytoplasmic sperm injection (ICSI) cycles at risk for OHSS. METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Assist Reprod Genet
Main Authors: Prapas, Yannis, Ravanos, Konstantinos, Petousis, Stamatios, Panagiotidis, Yannis, Papatheodorou, Achilleas, Margioula-Siarkou, Chrysoula, Iuliano, Assunta, Gullo, Giuseppe, Prapas, Nikos
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2017
Assuntos:
Assisted Reproduction Technologies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5699990/
https://ncbi.nlm.nih.gov/pubmed/28776117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10815-017-1010-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados